Viewpoint

   





The following are views expressed from a number of key practioners in the field of metabolomics

A Pharma Perspective on Metabolomics: Opportunities & Realities

          John Haselden, Director of Metabolomics, GSK

FDA’s Critical Path Initiative: Opportunities for Metabolomics

          Richard Beger, Center for Metabolomics, NCTR

 

   
   
©2008. The MPF is not responsible for the content of external internet sites. The MPF is a non-profit, non-partisan body.